Related Tags >> Velcade Takeda Phase III Amgen

Millennium Pharmaceuticals News

Most Popular Millennium Pharmaceuticals Story

Despite layoffs, scientists in high demand

September 26, 2008 — 11:20am ET | By Calisha Myers

Good news for scientists and researchers: despite a number of layoffs and hiring freezes, there is still high demand in the biotech industry. And human resources managers are going above and beyond... Read more...

Millennium Pharmaceuticals Press Releases

Seattle Genetics Announces Antibody-Drug Conjugate Collaboration With Millennium
Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer
Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer
PRESS RELEASE: FDA Expands Millennium Pharmaceuticals's VELCADE for Injection Label for Patients with Multiple Myeloma
PRESS RELEASE: Phase III Trial in Multiple Myeloma Stopped Early Due to Significant Efficacy Advantage of VELCADE

Latest Headlines

Despite layoffs, scientists in high demand
September 26, 2008
Takeda gains RNAi tech with $1B Alnylam deal
May 27, 2008
Millennium's Levin uses golden touch to fund start-up
April 29, 2008
Mass. biotechs ripe for buyouts
April 25, 2008
ALSO NOTED: AIDS vaccine researchers years away from success; Amgen reports earnings; and much more...
April 25, 2008
Takeda makes $8.8B bid for Millennium
April 10, 2008
Takeda makes $8.8B bid for Millennium
April 10, 2008
Millennium chief scientist takes offbeat approach
April 3, 2008
ALSO NOTED: Genentech options Exelixis inhibitor; Millennium reports positive data for cancer cocktail; Immtech CEO takes a pay
March 14, 2008
Millennium spent $1.3M on lobbying
February 8, 2008
ALSO NOTED: University spins off drug delivery company; Millennium Phase II meets goal; Will the FDA get money to flex muscles?
November 7, 2007
SPOTLIGHT: Positive Velcade data fuels stock rise
September 18, 2007
VC launches $378M fund
September 14, 2007
ALSO NOTED: Titan discontinues Phase II; Poniard lines up $15M; and much more...
October 25, 2006
Genzyme wins bidding war for AnorMED
October 16, 2006
Genzyme boosts AnorMED bid to $580M
October 9, 2006
DEALS: Merck KGaA buys Serono for $13.3B
September 27, 2006
Millennium to buy AnorMed for $515M
September 26, 2006
ALSO NOTED: Merck boosts stake in Schering; Lipitor studied for ALS; and much more...
June 8, 2006
SPOTLIGHT: Millennium Pharmaceuticals reaches $10M milestone
March 8, 2006

Paid Research Reports

More Research Reports >>